A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Top Cited Papers
Open Access
- 1 April 2010
- Vol. 141 (1), 69-80
- https://doi.org/10.1016/j.cell.2010.02.027
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- The X-Linked Mental Retardation Gene SMCX/JARID1C Defines a Family of Histone H3 Lysine 4 DemethylasesCell, 2007
- The Retinoblastoma Binding Protein RBP2 Is an H3K4 DemethylaseCell, 2007
- The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growthGenes & Development, 2007
- Microbial phenotypic heterogeneity and antibiotic toleranceCurrent Opinion in Microbiology, 2007
- Persister cells, dormancy and infectious diseaseNature Reviews Microbiology, 2006
- Clonal isolation of hESCs reveals heterogeneity within the pluripotent stem cell compartmentNature Methods, 2006
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapiesCancer Cell, 2006
- Epigenetics as a mechanism driving polygenic clinical drug resistanceBritish Journal of Cancer, 2006
- Retreatment of Lung Adenocarcinoma Patients With Gefitinib Who Had Experienced Favorable Results From Their Initial Treatment With This Selective Epidermal Growth Factor Receptor Inhibitor: A Report of Three CasesOncology Research, 2005